Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 11;11(10):319.
doi: 10.3390/jcdd11100319.

Prognostic Value of Coronary Artery Calcification in Patients with COVID-19 and Interstitial Pneumonia: A Case-Control Study

Affiliations

Prognostic Value of Coronary Artery Calcification in Patients with COVID-19 and Interstitial Pneumonia: A Case-Control Study

Gianni Dall'Ara et al. J Cardiovasc Dev Dis. .

Abstract

Background: Patients suffering from coronavirus disease-19 (COVID-19)-related interstitial pneumonia have variable outcomes, and the risk factors for a more severe course have yet to be comprehensively identified. Cohort studies have suggested that coronary artery calcium (CAC), as estimated at chest computed tomography (CT) scan, correlated with patient outcomes. However, given that the prevalence of CAC is gender- and age-dependent, the influence of baseline confounders cannot be completely excluded. Methods: We designed a retrospective, multicenter case-control study including patients with COVID-19, with severe course cases selected based on death within 30 days or requiring invasive ventilation, whereas controls were age- and sex-matched patients surviving up to 30 days without invasive ventilation. The primary outcome was the analysis of moderate-to-severe CAC prevalence between cases and controls. Results: A total of 65 cases and 130 controls were included in the study. Cases had a significantly higher median pulmonary severity score at chest CT scan compared to controls (10 vs. 8, respectively; p = 0.0001), as well as a higher CAC score (5 vs. 2; p = 0.009). The prevalence of moderate-to-severe CAC in cases was significantly greater (41.5% vs. 23.8%; p = 0.013), a difference mainly driven by a higher prevalence in those who died within 30 days (p = 0.000), rather than those requiring invasive ventilation (p = 0.847). White blood cell count, moderate-to-severe CAC, the need for antibiotic therapy, and severe pneumonia at CT scan were independent primary endpoint predictors. Conclusions: This case-control study demonstrated that the CAC burden was higher in COVID-19 patients who did not survive 30 days or who required mechanical ventilation, and CAC played an independent prognostic role.

Keywords: COVID-19; SARS-CoV-2; calcium score; coronary artery calcium; coronavirus disease-19; pulmonary severity score; severe acute respiratory syndrome coronavirus-2.

PubMed Disclaimer

Conflict of interest statement

All authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Coronary artery calcium (CAC) score distribution in cases and controls.
Figure 2
Figure 2
Anatomic recognition of the coronary segments with the highest calcium scores in the case group.
Figure 3
Figure 3
Primary endpoint of the study (A). Coronary artery calcium (CAC) distribution according to 30-day death (B) and need for invasive ventilation (C).
Figure 4
Figure 4
Receiver operating characteristic curve comparison between the two variables obtained from chest CT: pneumonia severity score and coronary artery calcium score.

Similar articles

References

    1. Bonow R.O., Fonarow G.C., O’Gara P.T., Yancy C.W. Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. 2020;5:751–753. doi: 10.1001/jamacardio.2020.1105. - DOI - PubMed
    1. Russell C.D., Lone N.I., Baillie J.K. Comorbidities, Multimorbidity and COVID-19. Nat. Med. 2023;29:334–343. doi: 10.1038/s41591-022-02156-9. - DOI - PubMed
    1. Kang Y., Chen T., Mui D., Ferrari V., Jagasia D., Scherrer-Crosbie M., Chen Y., Han Y. Cardiovascular Manifestations and Treatment Considerations in COVID-19. Heart. 2020;106:1132–1141. doi: 10.1136/heartjnl-2020-317056. - DOI - PMC - PubMed
    1. Zhao J., Xie Y., Meng Z., Liu C., Wu Y., Zhao F., Ma X., Christopher T.A., Lopez B.J., Wang Y. COVID-19 and Cardiovascular Complications: Updates of Emergency Medicine. Emerg. Crit. Care Med. 2023;3:104–114. doi: 10.1097/EC9.0000000000000095. - DOI - PMC - PubMed
    1. Chapman A.R., Bularga A., Mills N.L. High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19. Circulation. 2020;141:1733–1735. doi: 10.1161/CIRCULATIONAHA.120.047008. - DOI - PubMed

LinkOut - more resources